Sweden's Senzime Q2 sales fall on hospital contract delay
Sweden's Senzime Q2 sales fall on hospital contract delay
Overview
Sweden medical device firm's Q2 net sales fell 4% yr/yr, US sales down 6%
Q2 gross margin improved to 65.7% from 61.8% last yr
Company signed strategic partnership with Philips Medical Systems to expand global reach
Outlook
Senzime aims to achieve profitability by Q4 2026
Company expects continued margin improvements and disciplined cost management
Senzime expects additional U.S. tariff repayments totaling USD 350 thousand over coming quarters
Result Drivers
SENSOR SALES GROWTH - Co said recurring sensor sales increased 48% in local currencies, now making up about 80% of revenue, driven by greater utilization of TetraGraph systems
US MARKET WEAKNESS - Co said Q2 sales were affected by a slower US market and delays in expected hospital contracts
MARGIN IMPROVEMENT - Co attributed improved gross margin to increased operational focus and cost reductions, despite ongoing impact from US tariffs
Company press release: ID:nMFN6WPDXs
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Miss | SEK 24.67 mln | SEK 31 mln (1 Analyst) |
Q2 EPS |
| -SEK 0.14 |
|
Q2 Adjusted Gross Margin |
| 65.70% |
|
Analyst Coverage
Wall Street's median 12-month price target for Senzime AB (publ) is SEK9.50, about 130.9% above its July 15 closing price of SEK4.12
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract